Full Text View
Tabular View
No Study Results Posted
Related Studies
The Safety and Effectiveness of Low and High Carbohydrate Diets
This study is ongoing, but not recruiting participants.
Study NCT00079547   Information provided by National Center for Complementary and Alternative Medicine (NCCAM)
First Received: March 9, 2004   Last Updated: January 2, 2008   History of Changes

March 9, 2004
January 2, 2008
April 2003
March 2008   (final data collection date for primary outcome measure)
weight change [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00079547 on ClinicalTrials.gov Archive Site
  • change in lipids [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
  • blood pressure change [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
  • Ketones [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • Endothelial Function [ Time Frame: 2 ] [ Designated as safety issue: No ]
  • change in exercise endurance [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • change in renal function [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
  • change in bone density [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
  • change in body composition [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Same as current
 
The Safety and Effectiveness of Low and High Carbohydrate Diets
The Safety and Efficacy of Low and High Carbohydrate Diets

This study will compare the safety and the effectiveness of a low carbohydrate diet (Atkins diet) with a high carbohydrate diet (conventional USDA diet).

Despite the considerable mass appeal of popular diet books, such diet approaches lack data to support their efficacy and safety. Despite its widespread use for more than 30 years, the Atkins diet has never been evaluated in a large, randomized, controlled trial. This study will assess the short-term and long-term clinical effects of a low-carbohydrate diet and a high-carbohydrate diet in overweight and obese men and women.

Participants in this study will be randomly assigned to the Atkins diet (low-carbohydrate, unlimited fat and protein) or a conventional USDA diet (high-carbohydrate, low-fat). The study will evaluate the effects of each dietary approach on changes in: 1) weight and body composition; 2) metabolic and organ function; and 3) exercise tolerance. Each participant will be enrolled in the study for 2 years.

Phase IV
Interventional
Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study
Obesity
  • Behavioral: Low-calorie diet
  • Behavioral: low-carbohydrate diet
  • Active Comparator: Low-calorie diet
  • Experimental: Low-carbohydrate diet
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
307
March 2008
March 2008   (final data collection date for primary outcome measure)

Inclusion Criteria

  • Body mass index between 30 and 40
  • Live and work within 1 hour of the study site
  • Stable psychological status

Exclusion criteria

  • History of heart disease, heart attack, or stroke
  • Blood pressure >140/90 mmHg
  • Abnormal cholesterol levels
  • Significant psychiatric illness
  • Any medication that affects weight or metabolic rate
  • Presence or history of a chronic disease that is known to affect appetite, food intake, or metabolism (i.e., diabetes, thyroid disease, or cancer)
  • Currently using antidepressants, steroids, tobacco, or illegal drugs
  • Pregnant, breastfeeding, or planning pregnancy
  • 10 lb change in weight within 6 months of study entry
  • History of malignant arrhythmias or cerebrovascular, renal, or hepatic disease
  • History of protein wasting diseases or gout
  • Severe arthritis
  • Osteoporosis
  • Certain types of hormone replacement therapy
  • Currently following a vegetarian diet
Both
18 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00079547
Gary D. Foster, Ph.D., Temple University
R01 AT001103-01, R01 AT001103-01
National Center for Complementary and Alternative Medicine (NCCAM)
  • Office of Dietary Supplements (ODS)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Gary D Foster, PhD University of Pennsylvania
Principal Investigator: Holly Wyatt, MD University of Colorado at Denver and Health Sciences Center
Principal Investigator: James Hill, PhD University of Colorado at Denver and Health Sciences Center
Principal Investigator: Samuel Klein, MD Washington University School of Medicine
National Center for Complementary and Alternative Medicine (NCCAM)
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP